Literature DB >> 7506836

Benign prostatic hyperplasia: value of MR imaging for determining histologic type.

J Ishida1, K Sugimura, H Okizuka, Y Kaji, M Moriyama, S Nagaoka, M Mizutani, T Ishida.   

Abstract

PURPOSE: To assess the value of magnetic resonance (MR) imaging for determining the histologic type of benign prostatic hyperplasia (BPH).
MATERIALS AND METHODS: Unenhanced T1- and T2-weighted images and gadolinium-enhanced T1-weighted images were obtained in the transverse plane at 1.5 T in 33 patients with BPH. Hyperphasia was classified as stromal or nonstromal. Nonstromal hyperplasia was diagnosed if (a) the nodules in the inner gland had heterogeneous high signal intensity on T2-weighted images and peripheral enhancement on gadolinium-enhanced images, (b) a surgical capsule was present, or (c) the inner gland volume to total volume ratio was greater than 0.75.
RESULTS: A correct diagnosis was made with MR imaging in 23 of 24 patients with nonstromal hyperplasia and eight of nine with stromal hyperplasia (94% accuracy). In nonstromal hyperplasia, nodular lesions were seen in 20 patients and a surgical capsule was seen in 19. Eighteen patients had a transition zone ratio greater than 0.75.
CONCLUSION: MR imaging appears to be useful for choosing the type of pharmacotherapy performed because accurate histologic assessment is possible.

Entities:  

Mesh:

Year:  1994        PMID: 7506836     DOI: 10.1148/radiology.190.2.7506836

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

1.  Determination of the cutoff level of apparent diffusion coefficient values for detection of prostate cancer.

Authors:  Masako Nagayama; Yuji Watanabe; Akito Terai; Tohru Araki; Kenji Notohara; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  Jpn J Radiol       Date:  2011-09-01       Impact factor: 2.374

2.  Diagnosis of typical and atypical transition zone prostate cancer and its mimics at multiparametric prostate MRI.

Authors:  Jinxing Yu; Ann S Fulcher; Sarah G Winks; Mary A Turner; Ryan D Clayton; Michael Brooks; Sean Li
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

Review 3.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

4.  Use of MRI for Lobar Classification of Benign Prostatic Hyperplasia: Potential Phenotypic Biomarkers for Research on Treatment Strategies.

Authors:  Neil F Wasserman; Benjamin Spilseth; Jafar Golzarian; Gregory J Metzger
Journal:  AJR Am J Roentgenol       Date:  2015-09       Impact factor: 3.959

5.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

Review 6.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

7.  MRI Features Associated with Histology of Benign Prostatic Hyperplasia Nodules: Generation of a Predictive Model.

Authors:  Jessica C Dai; Tara N Morgan; Ramy Goueli; Daniel Parrott; Alexander Kenigsberg; Ryan J Mauck; Claus G Roehrborn; Douglas W Strand; Daniel N Costa; Jeffrey C Gahan
Journal:  J Endourol       Date:  2022-02-28       Impact factor: 2.619

8.  Prostate volumes derived from MRI and volume-adjusted serum prostate-specific antigen: correlation with Gleason score of prostate cancer.

Authors:  Ibrahim Karademir; Dinggang Shen; Yahui Peng; Shu Liao; Yulei Jiang; Ambereen Yousuf; Gregory Karczmar; Steffen Sammet; Shiyang Wang; Milica Medved; Tatjana Antic; Scott Eggener; Aytekin Oto
Journal:  AJR Am J Roentgenol       Date:  2013-11       Impact factor: 3.959

9.  Targeted biopsy based on ADC map in the detection and localization of prostate cancer: a feasibility study.

Authors:  Yuji Watanabe; Masako Nagayama; Tohru Araki; Akito Terai; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Satoru Nakashita; Yoshihiro Dodo
Journal:  J Magn Reson Imaging       Date:  2012-11-16       Impact factor: 4.813

10.  Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort study.

Authors:  Yuji Watanabe; Akito Terai; Tohru Araki; Masako Nagayama; Akira Okumura; Yoshiki Amoh; Takayoshi Ishimori; Mana Ishibashi; Satoru Nakashita; Yoshihiro Dodo
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.